Heart disease is the leading cause of death for people living with type 2 diabetes. Today the FDA approved a new use for one of our type 2 diabetes medicines, lowering the risk of major adverse cardiovascular events in adults with type 2 diabetes at high risk for these events. Read more:
顯示更多